investor450 said: "about time this started moving, I was...

investor450 said: "about time this started moving, I was starting to get bored, but no longer! "

I'll second that statement. We'll, at least the first part. BNO zigzagged for the past year. Knew its work would eventually get a partner, but biotech stocks tend to be plenty of hope but limited results. I held because BNO has multiple developments and some well alone. Yet, surprisingly, Merck's agreement isn't for any of BNO's developed efforts. Rather, for an early stage product, I gather.

As for the latter part of investor450's statement ("no longer"), I'm not sure. I'm hoping other big pharmas will see BNO's line-up and partner sooner, but I am also preparing myself for another siesta with this one.

But maybe, just maybe, Bell's $1.70 target price could become a reality sooner than I'm expecting!